Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Milestone Pharmaceuticals Inc (MIST)

Milestone Pharmaceuticals Inc (MIST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 168,630
  • Shares Outstanding, K 29,846
  • Annual Sales, $ 0 K
  • Annual Income, $ -49,970 K
  • 60-Month Beta 3.89
  • Price/Sales 14.23
  • Price/Cash Flow N/A
  • Price/Book 1.28
Trade MIST with:

Options Overview Details

View History
  • Implied Volatility 97.19%
  • Historical Volatility 42.16%
  • IV Percentile 31%
  • IV Rank 30.69%
  • IV High 292.23% on 02/18/21
  • IV Low 10.83% on 08/17/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 1,098

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.38
  • Number of Estimates 5
  • High Estimate -0.32
  • Low Estimate -0.52
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.36 +7.84%
on 09/21/21
6.42 -10.04%
on 08/27/21
+0.15 (+2.66%)
since 08/20/21
3-Month
5.25 +10.10%
on 08/10/21
6.42 -10.04%
on 08/27/21
-0.06 (-1.03%)
since 06/22/21
52-Week
5.09 +13.56%
on 04/19/21
9.03 -36.02%
on 02/04/21
-2.17 (-27.30%)
since 09/22/20

Most Recent Stories

More News
Milestone Pharmaceuticals to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

MONTREAL and CHARLOTTE, N.C., /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

MONTREAL and CHARLOTTE, N.C., /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals: Q2 Earnings Snapshot

MONTREAL (AP) _ Milestone Pharmaceuticals Inc. (MIST) on Wednesday reported second-quarter net income of $770,000, after reporting a loss in the same period a year earlier.

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update

MONTREAL and CHARLOTTE, N.C., /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

COMTEX_387314677/2669/2021-05-26T07:00:42

MIST : 5.78 (+2.30%)
Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase

Dr. Reddy's (RDY) earnings decline while sales grow year over year in fourth-quarter fiscal 2021.

RDY : 65.47 (-0.52%)
ADPT : 38.84 (+0.67%)
ADVM : 2.25 (unch)
MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals: Q1 Earnings Snapshot

MONTREAL (AP) _ Milestone Pharmaceuticals Inc. (MIST) on Monday reported a loss of $12.5 million in its first quarter.

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation of NODE-301 Data at ACC.21

MONTREAL and Charlotte, N.C., /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update

MONTREAL and CHARLOTTE, N.C., /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

MIST : 5.78 (+2.30%)
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China

MONTREAL and CHARLOTTE, N.C., /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

MIST : 5.78 (+2.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 6.15
2nd Resistance Point 5.94
1st Resistance Point 5.79
Last Price 5.78
1st Support Level 5.43
2nd Support Level 5.22
3rd Support Level 5.07

See More

52-Week High 9.03
Fibonacci 61.8% 7.53
Fibonacci 50% 7.06
Fibonacci 38.2% 6.60
Last Price 5.78
52-Week Low 5.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar